Search Results - "Setchell, Kenneth"
-
1
Equol: history, chemistry, and formation
Published in The Journal of nutrition (01-07-2010)“…Equol, first isolated from equine urine in 1932 and identified 50 years later in human urine as a metabolite of the soy isoflavones, daidzin and daidzein, is…”
Get more information
Journal Article -
2
Equol: pharmacokinetics and biological actions
Published in The Journal of nutrition (01-07-2010)“…Equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman], an isoflavan produced by intestinal bacteria in response to soy isoflavone intake in some but not all humans,…”
Get more information
Journal Article -
3
Method of defining equol-producer status and its frequency among vegetarians
Published in The Journal of nutrition (01-08-2006)“…7-Hydroxy-3-(4'-hydroxyphenyl)-chroman (S-equol) is a specific end-metabolite formed in the biotransformation of the dietary soy isoflavones daidzin and…”
Get more information
Journal Article -
4
The history and basic science development of soy isoflavones
Published in Menopause (New York, N.Y.) (01-12-2017)“…ABSTRACTThis review summarizes the 2016 NAMS/Pfizer—Wulf H. Utian Endowed Lecture that focused on the history and basic science of soy isoflavones. Described…”
Get full text
Journal Article -
5
Pharmacological inhibition of apical sodium‐dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice
Published in Hepatology (Baltimore, Md.) (01-02-2016)“…Deficiency of multidrug resistance 2 (mdr2), a canalicular phospholipid floppase, leads to excretion of low‐phospholipid “toxic” bile causing progressive…”
Get full text
Journal Article -
6
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study
Published in The Lancet (British edition) (30-10-2021)“…Alagille syndrome is a rare genetic disease that often presents with severe cholestasis and pruritus. There are no approved drugs for management. Maralixibat,…”
Get full text
Journal Article -
7
Open‐label Phase 3 Continuation Study of Cholic Acid in Patients With Inborn Errors of Bile Acid Synthesis
Published in Journal of pediatric gastroenterology and nutrition (01-04-2020)“…ABSTRACT Background: In patients with bile acid synthesis disorders (BASD), impairment in the primary bile acid synthetic pathway leads to reduced primary bile…”
Get full text
Journal Article -
8
Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
Published in Journal of pediatric gastroenterology and nutrition (01-09-2017)“…ABSTRACT Objectives: Patients with bile acid synthesis disorders (BASDs) due to single enzyme defects (SEDs) or Zellweger spectrum disorders (ZSDs) accumulate…”
Get full text
Journal Article -
9
Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice
Published in Science translational medicine (21-09-2016)“…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, and safe and effective therapies are needed. Bile acids…”
Get more information
Journal Article -
10
Urinary sphingolipids in adolescents and young adults with youth-onset diabetes
Published in Pediatric nephrology (Berlin, West) (01-06-2024)“…Background This study evaluated urinary sphingolipids as a marker of diabetic kidney disease (DKD) in adolescents and young adults with youth-onset type 1 and…”
Get full text
Journal Article -
11
The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones
Published in The Journal of nutrition (01-12-2002)“…Equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman] is a nonsteroidal estrogen of the isoflavone class. It is exclusively a product of intestinal bacterial…”
Get more information
Journal Article -
12
Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk
Published in The American journal of clinical nutrition (01-11-2011)“…Human and animal studies have produced conflicting results with regard to the effect of soy isoflavones on breast cancer risk. This may be due to differences…”
Get full text
Journal Article -
13
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology
Published in PloS one (30-03-2015)“…Gaucher disease (GD) is caused by insufficient activity of acid β-glucosidase (GCase) resulting from mutations in GBA1. To understand the pathogenesis of the…”
Get full text
Journal Article -
14
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis
Published in Science translational medicine (14-12-2022)“…Immune-mediated bile duct epithelial injury and toxicity of retained hydrophobic bile acids drive disease progression in fibrosing cholangiopathies such as…”
Get more information
Journal Article -
15
Bile Acid Profiling Reveals Distinct Signatures in Undernourished Children with Environmental Enteric Dysfunction
Published in The Journal of nutrition (01-12-2021)“…Intestinal inflammation and malabsorption in environmental enteric dysfunction (EED) are associated with early childhood growth faltering in impoverished…”
Get more information
Journal Article -
16
Inborn Errors of Bile Acid Metabolism
Published in Clinics in liver disease (01-11-2018)“…Inborn errors of bile acid metabolism are rare causes of neonatal cholestasis and liver disease in older children and adults. The diagnosis should be…”
Get full text
Journal Article -
17
Weight Loss Induced by Roux-en-Y Gastric Bypass But Not Laparoscopic Adjustable Gastric Banding Increases Circulating Bile Acids
Published in The journal of clinical endocrinology and metabolism (01-04-2013)“…Context: It has been hypothesized that increased plasma bile acids (BAs) contribute to metabolic improvements after Roux-en-Y gastric bypass (RYGB) surgery by…”
Get full text
Journal Article -
18
Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease
Published in Science translational medicine (09-10-2013)“…Parenteral nutrition-associated liver disease (PNALD) is a serious complication of PN in infants who do not tolerate enteral feedings, especially those with…”
Get more information
Journal Article -
19
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, GBA1 mutation-associated pathologies and diseases
Published in Proceedings of the National Academy of Sciences - PNAS (03-01-2023)“…Mutations in , encoding glucocerebrosidase (GCase), cause Gaucher disease (GD) and are also genetic risks in developing Parkinson's disease (PD). Currently,…”
Get full text
Journal Article -
20
Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight‐loss‐independent manner
Published in Obesity (Silver Spring, Md.) (01-02-2014)“…Objective Our objective was to investigate the role of bile acids in hepatic steatosis reduction after vertical sleeve gastrectomy (VSG). Design and Methods…”
Get full text
Journal Article